List of Excipients in API isosorbide dinitrate and hydralazine hydrochloride
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing isosorbide dinitrate and hydralazine hydrochloride
Detailed excipient profiles for isosorbide dinitrate and hydralazine hydrochloride
Excipient focus: ANHYDROUS LACTOSE
isosorbide dinitrate and hydralazine hydrochloride drug variants containing ANHYDROUS LACTOSE
isosorbide dinitrate and hydralazine hydrochloride drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
isosorbide dinitrate and hydralazine hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
isosorbide dinitrate and hydralazine hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
isosorbide dinitrate and hydralazine hydrochloride drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | isosorbide dinitrate and hydralazine hydrochloride | 50742-246 |
| >Company | >Ingredient | >NDC |
isosorbide dinitrate and hydralazine hydrochloride drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| i3 Pharmaceuticals LLC | isosorbide dinitrate and hydralazine hydrochloride | 72319-012 |
| A2A Integrated Pharmaceuticals | isosorbide dinitrate and hydralazine hydrochloride | 73141-012 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
isosorbide dinitrate and hydralazine hydrochloride drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | isosorbide dinitrate and hydralazine hydrochloride | 50742-246 |
| >Company | >Ingredient | >NDC |
isosorbide dinitrate and hydralazine hydrochloride drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| i3 Pharmaceuticals LLC | isosorbide dinitrate and hydralazine hydrochloride | 72319-012 |
| A2A Integrated Pharmaceuticals | isosorbide dinitrate and hydralazine hydrochloride | 73141-012 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
isosorbide dinitrate and hydralazine hydrochloride drug variants containing FD&C YELLOW NO. 6
isosorbide dinitrate and hydralazine hydrochloride drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
isosorbide dinitrate and hydralazine hydrochloride drug variants containing HYPROMELLOSE
isosorbide dinitrate and hydralazine hydrochloride drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
isosorbide dinitrate and hydralazine hydrochloride drug variants containing MAGNESIUM STEARATE
isosorbide dinitrate and hydralazine hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
isosorbide dinitrate and hydralazine hydrochloride drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | isosorbide dinitrate and hydralazine hydrochloride | 50742-246 |
| >Company | >Ingredient | >NDC |
isosorbide dinitrate and hydralazine hydrochloride drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| i3 Pharmaceuticals LLC | isosorbide dinitrate and hydralazine hydrochloride | 72319-012 |
| A2A Integrated Pharmaceuticals | isosorbide dinitrate and hydralazine hydrochloride | 73141-012 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
isosorbide dinitrate and hydralazine hydrochloride drug variants containing POLYETHYLENE GLYCOL
isosorbide dinitrate and hydralazine hydrochloride drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
isosorbide dinitrate and hydralazine hydrochloride drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| i3 Pharmaceuticals LLC | isosorbide dinitrate and hydralazine hydrochloride | 72319-012 |
| A2A Integrated Pharmaceuticals | isosorbide dinitrate and hydralazine hydrochloride | 73141-012 |
| >Company | >Ingredient | >NDC |
isosorbide dinitrate and hydralazine hydrochloride drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | isosorbide dinitrate and hydralazine hydrochloride | 50742-246 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
isosorbide dinitrate and hydralazine hydrochloride drug variants containing SILICON DIOXIDE
isosorbide dinitrate and hydralazine hydrochloride drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
isosorbide dinitrate and hydralazine hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
isosorbide dinitrate and hydralazine hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
isosorbide dinitrate and hydralazine hydrochloride drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | isosorbide dinitrate and hydralazine hydrochloride | 50742-246 |
| >Company | >Ingredient | >NDC |
isosorbide dinitrate and hydralazine hydrochloride drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| i3 Pharmaceuticals LLC | isosorbide dinitrate and hydralazine hydrochloride | 72319-012 |
| A2A Integrated Pharmaceuticals | isosorbide dinitrate and hydralazine hydrochloride | 73141-012 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
isosorbide dinitrate and hydralazine hydrochloride drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| i3 Pharmaceuticals LLC | isosorbide dinitrate and hydralazine hydrochloride | 72319-012 |
| A2A Integrated Pharmaceuticals | isosorbide dinitrate and hydralazine hydrochloride | 73141-012 |
| >Company | >Ingredient | >NDC |
isosorbide dinitrate and hydralazine hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | isosorbide dinitrate and hydralazine hydrochloride | 50742-246 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
isosorbide dinitrate and hydralazine hydrochloride drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | isosorbide dinitrate and hydralazine hydrochloride | 50742-246 |
| >Company | >Ingredient | >NDC |
isosorbide dinitrate and hydralazine hydrochloride drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| i3 Pharmaceuticals LLC | isosorbide dinitrate and hydralazine hydrochloride | 72319-012 |
| A2A Integrated Pharmaceuticals | isosorbide dinitrate and hydralazine hydrochloride | 73141-012 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
